Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1966 1
1980 3
1981 1
1982 1
1983 1
1984 1
1987 3
1988 2
1989 3
1993 1
1994 3
1995 3
1996 2
1997 3
2000 2
2002 3
2004 4
2005 3
2006 4
2007 3
2008 1
2009 3
2010 4
2011 5
2012 9
2013 6
2014 7
2015 5
2016 9
2017 14
2018 8
2019 15
2020 7
2021 6
2022 16
2023 17
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology.
Tsujikawa K, Hamanaka K, Riku Y, Hattori Y, Hara N, Iguchi Y, Ishigaki S, Hashizume A, Miyatake S, Mitsuhashi S, Miyazaki Y, Kataoka M, Jiayi L, Yasui K, Kuru S, Koike H, Kobayashi K, Sahara N, Ozaki N, Yoshida M, Kakita A, Saito Y, Iwasaki Y, Miyashita A, Iwatsubo T; Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI); Ikeuchi T; Japanese Longitudinal Biomarker Study in PSP and CBD (JALPAC) Consortium; Miyata T, Sobue G, Matsumoto N, Sahashi K, Katsuno M. Tsujikawa K, et al. Among authors: hashizume a. Sci Adv. 2022 May 27;8(21):eabm5029. doi: 10.1126/sciadv.abm5029. Epub 2022 May 25. Sci Adv. 2022. PMID: 35613261 Free PMC article.
Autoantibodies Against Dihydrolipoamide S-Acetyltransferase in Immune-Mediated Neuropathies.
Fukami Y, Iijima M, Koike HH, Yagi S, Furukawa S, Mouri N, Ouchida J, Murakami A, Iida M, Yokoi S, Hashizume A, Iguchi Y, Imagama S, Katsuno M. Fukami Y, et al. Among authors: hashizume a. Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200199. doi: 10.1212/NXI.0000000000200199. Epub 2024 Jan 5. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38181320 Free PMC article.
Preclinical progression of neurodegenerative diseases.
Katsuno M, Sahashi K, Iguchi Y, Hashizume A. Katsuno M, et al. Among authors: hashizume a. Nagoya J Med Sci. 2018 Aug;80(3):289-298. doi: 10.18999/nagjms.80.3.289. Nagoya J Med Sci. 2018. PMID: 30214078 Free PMC article. Review.
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.
Yamada S, Hashizume A, Hijikata Y, Inagaki T, Ito D, Kishimoto Y, Kinoshita F, Hirakawa A, Shimizu S, Nakamura T, Katsuno M. Yamada S, et al. Among authors: hashizume a. Ann Clin Transl Neurol. 2022 Nov;9(11):1702-1714. doi: 10.1002/acn3.51667. Epub 2022 Oct 8. Ann Clin Transl Neurol. 2022. PMID: 36208052 Free PMC article. Clinical Trial.
Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan.
Mori-Yoshimura M, Suzuki N, Katsuno M, Takahashi MP, Yamashita S, Oya Y, Hashizume A, Yamada S, Nakamori M, Izumi R, Kato M, Warita H, Tateyama M, Kuroda H, Asada R, Yamaguchi T, Nishino I, Aoki M. Mori-Yoshimura M, et al. Among authors: hashizume a. Orphanet J Rare Dis. 2023 Aug 11;18(1):241. doi: 10.1186/s13023-023-02850-y. Orphanet J Rare Dis. 2023. PMID: 37568154 Free PMC article. Clinical Trial.
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Tokumaru AM, Sakurai K, Murayama S, Hasegawa K, Uchihara T, Toyoshima Y, Saito Y, Yabe I, Tanikawa S, Sugaya K, Hayashi K, Sano T, Takao M, Sakai M, Fujimura H, Takigawa H, Adachi T, Hanajima R, Yokota O, Miki T, Iwasaki Y, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Tanaka M, Idezuka J, Kanazawa M, Aoki K, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Mukai E, Kubota A, Toda T, Nakashima K; J-VAC study group. Aiba I, et al. Among authors: hashizume a. Brain Commun. 2023 Nov 3;5(6):fcad296. doi: 10.1093/braincomms/fcad296. eCollection 2023. Brain Commun. 2023. PMID: 38090279 Free PMC article.
Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study.
Sakurai K, Tokumaru AM, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Hayashi Y, Shimohata T, Murayama S, Iwasaki Y, Uchihara T, Sakai M, Yabe I, Tanikawa S, Takigawa H, Adachi T, Hanajima R, Fujimura H, Hayashi K, Sugaya K, Hasegawa K, Sano T, Takao M, Yokota O, Miki T, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Idezuka J, Toyoshima Y, Kanazawa M, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Kubota A, Toda T, Nakashima K, Aiba I; J-VAC study group. Sakurai K, et al. Among authors: hashizume a. Neuroradiology. 2024 Nov;66(11):1917-1929. doi: 10.1007/s00234-024-03432-w. Epub 2024 Jul 22. Neuroradiology. 2024. PMID: 39039147 Free PMC article.
The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report.
Nakatsuji H, Ikeda T, Hashizume A, Katsuno M, Sobue G, Nakajima T. Nakatsuji H, et al. Among authors: hashizume a. Front Neurol. 2022 Jun 24;13:905613. doi: 10.3389/fneur.2022.905613. eCollection 2022. Front Neurol. 2022. PMID: 35812096 Free PMC article.
183 results